# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
CARGO shares rose after announcing a buyout deal with Concentra, including cash and potential future payouts tied to asset sales.
Jefferies analyst Michael Yee maintains Cargo Therapeutics (NASDAQ:CRGX) with a Hold and raises the price target from $3.7 t...
Concentra will acquire CARGO for $4.379 in cash per share of CARGO common stock, par value $0.001 per share ("CARGO Common ...
- Development of CRG-023 and allogeneic platform suspended; further reduction in force (RIF) of approximately 90% to preserve c...
Truist Securities analyst Asthika Goonewardene downgrades Cargo Therapeutics (NASDAQ:CRGX) from Buy to Hold and lowers the p...